Phosphodiesterase 3 (PDE3) inhibitors
AU2026230132A1Pending Publication Date: 2026-10-01ZOETIS SERVICES LLC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026230132
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-01-30
- Filing Date
- 2026-09-10
- Publication Date
- 2026-10-01
Abstract
Abstract The invention describes novel PDE3 inhibitors for treating a cardiovascular disease including myxomatous mitral valve disease, congestive heart failure and / or asymptomatic heart failure in animals, particularly canines Abstract canines
Need to check novelty before this filing date? Find Prior Art